Arcturus Therapeutics Holdings (ARCT)
(Delayed Data from NSDQ)
$27.93 USD
+1.17 (4.38%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $27.92 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Earnings News For ARCT
-
Arcturus Therapeutics: Q4 Earnings Snapshot
-
Arcturus Therapeutics: Q4 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
-
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
-
Arcturus Therapeutics: Q3 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates
-
Arcturus Therapeutics: Q2 Earnings Snapshot
-
Arcturus Therapeutics: Q1 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Q1 Earnings and Revenues Miss Estimates
-
Arcturus Therapeutics (ARCT) Beats Q4 Earnings and Revenue Estimates
-
Arcturus Therapeutics: Q4 Earnings Snapshot
-
Arcturus Therapeutics: Q3 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Tops Revenue Estimates
-
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates
-
Arcturus Therapeutics: Q2 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates
-
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
-
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
-
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates
-
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline
-
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates
-
Earnings Preview: Arcturus Therapeutics (ARCT) Q2 Earnings Expected to Decline
-
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates
-
Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline
-
Earnings Preview: Arcturus Therapeutics (ARCT) Q4 Earnings Expected to Decline